Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Actions On Rx Drug Promos Covered New Territory Last Year

Jan 12 2021

• By Brenda Sandburg

2020-2021 PINK SHEET PERSPECTIVES - Megaphone — FDA issued fewer Rx drug promo enforcement letters in 2020 while initiating six new research projects • Source: Shutterstock

Related Content

Contrave TV Ad's Slimmed Down Adverse Events Draw FDA Rebuke

May 25 2017

Internet Searching May Get ‘Riskier’ For Patients After FDA Citations

Apr 06 2009

Advertising Enforcement: US FDA Content To Let Competitors 'Duke It Out,' Woodcock Says

Sep 24 2018

Xtampza ER Warnings Can't Be Hidden Behind Table And Chairs, US FDA Tells Collegium

Feb 22 2018

US FDA Aims For More Timely Reviews Of Rx Drug Launch Promotions

Nov 09 2020

New Social Media Guidance From US FDA May Be On The Horizon

Nov 04 2020

Rx Drug Promotion Studies Target Biosimilar Disclosures, Unapproved Uses, Multiple Indications

Jul 07 2020

Drug Promotion: Consumers Prefer Live Action Over Animated Characters In TV Ads

May 25 2020

Azurity’s Xatmep Promotional Email To Healthcare Professionals Gets Dinged By US FDA

Dec 04 2020

US FDA Reprimands Arog Pharmaceuticals For Promo Of Investigational AML Drug

Jul 12 2018

Addyi Radio Ad’s Lack Of Alcohol Risk Information Elicits New Clash With US FDA

Sep 16 2020

US FDA To Screen Rx Drug Launch Promos Prior To Initiating Review

Dec 17 2020

Power Of Proprietary Drug Names To Be Studied By US FDA

Jan 20 2020

Celebrity Takes Role In US FDA Study Of Rx Drug Endorsements

Jan 27 2020

Tom Abrams’ Steady Leadership Guided US FDA Through Dramatic Changes In Rx Promotion

Oct 28 2020

Related Companies

Nephron Pharmaceuticals Corporation

Sprout Pharmaceuticals, Inc.

Nalpropion Pharmaceuticals, Inc.

Orexigen Therapeutics, Inc.

Outlook Pharmaceuticals, Inc.

Azurity Pharmaceuticals, Inc.

Mylan Pharmaceuticals Inc.

Additional Topics

United States Advertising, Marketing & Sales FDA Regulation Pink Sheet Perspectives BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window